how overweight for glp-1 weight loss is driven mainly by fat loss, not muscle loss Cardiometabolic effects of GLP-1 analogs

Information about data access request proposals can be found at Change history 28 May 2024 In the version of the article initially published, in Fig

Metabolism 164:156113 Linge J, Birkenfeld AL, Neeland IJ (2024) Muscle mass and Glucagon-Like Peptide-1 receptor agonists: adaptive or maladaptive response to weight loss

Similar content being viewed by others Subjects Introduction Obesity-induced muscle atrophy is a clinical syndrome characterized by the progressive loss of skeletal muscle mass and function under obesogenic conditions 1

Top GLP-1 Tracking Apps: Why it matters

Would you need to administer these two peptides at the same time